Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 15 X posts from 9 X users, with an upper bound of 34,487 followers.

#JITC Commentary: Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis https://t.co/nYaFKRvceK

23 Jan 2019

Reply Repost Favourite

RT @sitcancer: #JITC Commentary: Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibi…

19 Jan 2019

Reply Repost Favourite

RT @sitcancer: #JITC Commentary: Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibi…

18 Jan 2019

Reply Repost Favourite

#JITC Commentary: Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis https://t.co/nYaFKRvceK

18 Jan 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.